Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Natera Inc (NTRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,536,907
  • Shares Outstanding, K 60,940
  • Annual Sales, $ 210,940 K
  • Annual Income, $ -136,310 K
  • 36-Month Beta 2.12
  • Price/Sales 7.11
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.47
  • Number of Estimates 3
  • High Estimate -0.43
  • Low Estimate -0.52
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +7.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.15 +19.24%
on 07/20/18
26.21 -3.78%
on 08/14/18
+2.50 (+11.00%)
since 07/17/18
3-Month
11.26 +123.98%
on 05/24/18
26.21 -3.78%
on 08/14/18
+13.44 (+114.09%)
since 05/17/18
52-Week
8.60 +193.26%
on 04/03/18
26.21 -3.78%
on 08/14/18
+14.10 (+126.80%)
since 08/17/17

Most Recent Stories

More News
GOLD PR | Social Media Named to the 2018 Inc. 5000 List of America's Fastest-Growing Private Companies

GOLD PR, a top marketing communications agency with offices in Orange County, Calif. and New York, announced that it was ranked #3172 on the 2018 Inc. 5000 list, which is the most prominent ranking of...

NTRA : 25.22 (unch)
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -5.77% and 3.49%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

NTRA : 25.22 (unch)
Natera, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Natera, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 4:30:00 PM Eastern Time.

NTRA : 25.22 (unch)
What's in Store for Penumbra (PEN) This Earnings Season?

Penumbra (PEN) deepens focus on driving innovation, ramping up production and expanding geographies.

EYE : 40.46 (+1.98%)
NTRA : 25.22 (unch)
PEN : 125.70 (-2.03%)
ARDX : 3.95 (-3.66%)
Can Dental Growth Drive Henry Schein's (HSIC) Q2 Earnings?

Henry Schein (HSIC) is strongly placed to gain from the ongoing trend of digitalization in the global dental market.

EYE : 40.46 (+1.98%)
NTRA : 25.22 (unch)
HSIC : 80.34 (+1.48%)
ARDX : 3.95 (-3.66%)
Study Shows Natera's Spectrum Preimplantation Genetic Testing for Aneuploidy Improves IVF Outcomes for All Women, Regardless of Maternal Age

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing, today announced the publication of a study demonstrating the value of the company's Spectrum® preimplantation genetic screening for...

NTRA : 25.22 (unch)
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience

Natera (NASDAQ: NTRA), a leader in non-invasive genetic testing, has appointed Roy Baynes, MB.BCh., M.Med., PhD, FCP, FACP, Chief Medical Officer at Merck, and Senior Vice President and Head of Global...

NTRA : 25.22 (unch)
MRK : 69.06 (+0.31%)
Can The Uptrend Continue for Natera (NTRA)?

Natera, Inc. (NTRA) has been on the move lately as the stock has climbed in the past four weeks

NTRA : 25.22 (unch)
Natera (NTRA) Catches Eye: Stock Jumps 6.3%

Natera (NTRA) shares rose more than 6% in the last trading session, amid huge volumes.

NTRA : 25.22 (unch)
BEAT : 56.95 (+2.80%)
Natera Announces Pricing of Follow-On Offering

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced the pricing of its underwritten public offering of 4,500,000 shares...

NTRA : 25.22 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade NTRA with:

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

2nd Resistance Point 25.73
1st Resistance Point 25.48
Last Price 25.22
1st Support Level 24.79
2nd Support Level 24.35

See More

52-Week High 26.21
Last Price 25.22
Fibonacci 61.8% 19.48
Fibonacci 50% 17.40
Fibonacci 38.2% 15.33
52-Week Low 8.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar